Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (80599)	10/1/2002 8:54:24 PM
From: afrayem onigwecher	Respond to of 122087

GeneMax Corp. Announces 144 Reporting Error 7/19/2002 9:30:00 AM BLAINE, Wash., Jul 19, 2002 /PRNewswire-FirstCall via COMTEX/ -- 144 Reporting Error: GeneMax Corp. ("the Company") (GMXX) announced today that Lexington Merchantile Corp. filed an erroneous Form 144 report on or about July 10, 2002 that falsely indicated that it intended to sell 100,000 restricted common shares in the capital of the Company. The report was erroneous and has not been corrected at the date of this news release. The Company confirms that Lexington Merchantile has never owned more than 2,000 shares of GeneMax Corp., formerly named eduverse.com. The 144 report should have therefore reflect a total of 2,000 restricted common shares. SAFE HARBOR STATEMENT This news release may include forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the company's analysis of opportunities in the acquisition and development of various project interests and certain other matters. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein. MAKE YOUR OPINION COUNT - Click Here tbutton.prnewswire.com SOURCE GeneMax Corp. CONTACT: Marcus Johnson, +1-866-872-0077, or +1-360-332-7734, or fax, +1-360-332-1643, for GeneMax Corp. (GMXX) prnewswire.com Copyright (C) 2002 PR Newswire. All rights reserved.